Healthcare provider profile · identity verified

Robert A Tribuzio, MD

Internal Medicine · LANCASTER, PA · NPI 1619910130

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	494	142
Lisinopril	Lisinopril	318	88
Levothyroxine Sodium	Levothyroxine Sodium	303	88
Metformin Hcl	Metformin Hcl	269	70
Omeprazole	Omeprazole	260	79
Amlodipine Besylate	Amlodipine Besylate	223	61
Simvastatin	Simvastatin	216	60
Metoprolol Succinate	Metoprolol Succinate	159	51
Rosuvastatin Calcium	Rosuvastatin Calcium	150	53
Losartan Potassium	Losartan Potassium	147	44
Pantoprazole Sodium	Pantoprazole Sodium	141	43
Eliquis	Apixaban	131	31
Gabapentin	Gabapentin	126	38
Hydrochlorothiazide	Hydrochlorothiazide	124	38
Metoprolol Tartrate	Metoprolol Tartrate	115	34
Escitalopram Oxalate	Escitalopram Oxalate	113	37
Allopurinol	Allopurinol	111	30
Tamsulosin Hcl	Tamsulosin Hcl	96	30
Trazodone Hcl	Trazodone Hcl	89	28
Alprazolam	Alprazolam	88	26
Famotidine	Famotidine	86	27
Montelukast Sodium	Montelukast Sodium	86	26
Furosemide	Furosemide	79	30
Albuterol Sulfate Hfa	Albuterol Sulfate	76	33
Citalopram Hbr	Citalopram Hydrobromide	76	19
Synthroid	Levothyroxine Sodium	76	25
Glimepiride	Glimepiride	71	22
Clopidogrel	Clopidogrel Bisulfate	69	17
Tramadol Hcl	Tramadol Hcl	67	23
Lorazepam	Lorazepam	64	22
Atenolol	Atenolol	62	16
Fluoxetine Hcl	Fluoxetine Hcl	60	17
Oxycodone Hcl	Oxycodone Hcl	56	14
Pravastatin Sodium	Pravastatin Sodium	55	17
Sertraline Hcl	Sertraline Hcl	55	13
Mirtazapine	Mirtazapine	54	19
Nifedipine Er	Nifedipine	53	11
Duloxetine Hcl	Duloxetine Hcl	51	18
Finasteride	Finasteride	51	14
Ezetimibe	Ezetimibe	50	15
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	49	24
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	49	18
Pregabalin	Pregabalin	48	11
Trulicity	Dulaglutide	48	suppressed
Celecoxib	Celecoxib	47	13
Metformin Hcl Er	Metformin Hcl	46	13
Buspirone Hcl	Buspirone Hcl	45	14
Pioglitazone Hcl	Pioglitazone Hcl	44	13
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	43	13
Zolpidem Tartrate	Zolpidem Tartrate	43	18
Arexvy	Rsvpref3 Antigen/As01e/Pf	40	40
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	40	12
Fluticasone Propionate	Fluticasone Propionate	39	17
Venlafaxine Hcl Er	Venlafaxine Hcl	35	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	34	16
Lovastatin	Lovastatin	33	suppressed
Bupropion Xl	Bupropion Hcl	32	suppressed
Glipizide Er	Glipizide	32	suppressed
Potassium Chloride	Potassium Chloride	32	suppressed
Carvedilol	Carvedilol	31	12
Warfarin Sodium	Warfarin Sodium	31	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	30	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	29	suppressed
Irbesartan	Irbesartan	29	12
Ozempic	Semaglutide	29	suppressed
Prednisone	Prednisone	29	25
Jardiance	Empagliflozin	26	suppressed
Alendronate Sodium	Alendronate Sodium	25	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	24	suppressed
Morphine Sulfate	Morphine Sulfate	24	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	23	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	23	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	22	20
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	22	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	21	19
Clonazepam	Clonazepam	20	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	20	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	20	suppressed
Terazosin Hcl	Terazosin Hcl	20	suppressed
Breo Ellipta	Fluticasone/Vilanterol	19	suppressed
Bupropion Hcl Sr	Bupropion Hcl	19	suppressed
Paroxetine Hcl	Paroxetine Hcl	19	suppressed
Xarelto	Rivaroxaban	19	suppressed
Benazepril Hcl	Benazepril Hcl	18	suppressed
Hydralazine Hcl	Hydralazine Hcl	18	suppressed
Mounjaro	Tirzepatide	18	suppressed
Rizatriptan	Rizatriptan Benzoate	18	suppressed
Valacyclovir	Valacyclovir Hcl	18	suppressed
Baclofen	Baclofen	17	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	17	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	17	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	17	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	17	suppressed
Tresiba Flextouch U-100	Insulin Degludec	17	suppressed
Estradiol	Estradiol	16	suppressed
Meloxicam	Meloxicam	16	suppressed
Methylprednisolone	Methylprednisolone	16	16
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	16	suppressed
Glipizide	Glipizide	15	suppressed
Spironolactone	Spironolactone	15	suppressed
Valsartan	Valsartan	15	suppressed
Chlorthalidone	Chlorthalidone	14	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	14	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	14	suppressed
Ropinirole Hcl	Ropinirole Hcl	14	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	13	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	13	suppressed
Januvia	Sitagliptin Phosphate	13	suppressed
Novolog Flexpen	Insulin Aspart	13	suppressed
Amiloride-Hydrochlorothiazide	Amiloride/Hydrochlorothiazide	12	suppressed
Breyna	Budesonide/Formoterol Fumarate	12	suppressed
Diclofenac Sodium	Diclofenac Sodium	12	suppressed
Effexor Xr	Venlafaxine Hcl	12	suppressed
Enalapril Maleate	Enalapril Maleate	12	suppressed
Entresto	Sacubitril/Valsartan	12	suppressed
Felodipine Er	Felodipine	12	suppressed
Jantoven	Warfarin Sodium	12	suppressed
Meclizine Hcl	Meclizine Hcl	12	suppressed
Morphine Sulfate Er	Morphine Sulfate	12	suppressed
Naproxen	Naproxen	12	suppressed
Ursodiol	Ursodiol	12	suppressed
Amoxicillin	Amoxicillin	11	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	11	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	11	suppressed
Dutasteride	Dutasteride	11	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	11	suppressed
Tizanidine Hcl	Tizanidine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error